GeneLeap Announces Novel GalNAc Synthesis and Evaluation in Mice as Antisense Oligonucleotide Conjugates at ACS 2021 ...Middle East

PR Newswire - News
GeneLeap Announces Novel GalNAc Synthesis and Evaluation in Mice as Antisense Oligonucleotide Conjugates at ACS 2021
BOSTON, April 25, 2021 /PRNewswire/ -- GeneLeap Biotech, a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an e-poster entitled 'Design and synthesis of novel GalNAc linker moieties, conjugation to antisense oligonucleotides and...

Hence then, the article about geneleap announces novel galnac synthesis and evaluation in mice as antisense oligonucleotide conjugates at acs 2021 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GeneLeap Announces Novel GalNAc Synthesis and Evaluation in Mice as Antisense Oligonucleotide Conjugates at ACS 2021 )

Apple Storegoogle play

Last updated :

Also on site :